Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7573971

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,702,000,000 JPY
2,926,000,000 JPY
Non-operating income
Non-operating income
712,000,000 JPY
654,000,000 JPY
Non-operating expenses
Non-operating expenses
78,000,000 JPY
65,000,000 JPY
Ordinary profit (loss)
5,336,000,000 JPY
3,515,000,000 JPY
Extraordinary income
Extraordinary income
1,332,000,000 JPY
0 JPY
Extraordinary losses
Extraordinary losses
707,000,000 JPY
17,000,000 JPY
Profit (loss) before income taxes
5,961,000,000 JPY
3,498,000,000 JPY
Profit (loss)
4,377,000,000 JPY
2,483,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.